Randomized placebo-controlled intervention with n-3 LC-PUFA-supplemented yoghurt: Effects on circulating eicosanoids and cardiovascular risk factors

Clinical Nutrition

Volumn 32, Issue 5, 2013, Pages 686-696

  Dawczynski, Christine ^a   Massey, Karen A ^b   Ness, Christina ^a   Kiehntopf, Michael ^a   Stepanow, Stefanie ^c   Platzer, Matthias ^c   Grün, Michael ^a   Nicolaou, Anna ^b   Jahreis, Gerhard ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

^c Leibnitz Institute for Age Research   (Germany)

Author keywords

Blood lipids; Cytokines; Dairy products; Eicosanoids; N 3 LC PUFA

Indexed keywords

12 HYDROXYEICOSAPENTAENOIC ACID; 15 HYDROXYEICOSAPENTAENOIC ACID; 18 HYDROXYEICOSAPENTAENOIC ACID; 9 HYDROXYARACHIDONIC ACID; 9 HYDROXYOCTADECAENOIC ACID; C REACTIVE PROTEIN; CD36 ANTIGEN; CONJUGATED LINOLEIC ACID; DIHOMO GAMMA LINOLENIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID DERIVATIVE; GAMMA INTERFERON; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; INTERLEUKIN 2; INTERLEUKIN 6; LINOLEIC ACID; LINOLENIC ACID; LONG CHAIN FATTY ACID; MONOUNSATURATED FATTY ACID; OLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PLACEBO; PROSTAGLANDIN E3; SATURATED FATTY ACID; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; YOGHURT;

ADULT; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CD36 GENE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DIETARY FIBER; DOUBLE BLIND PROCEDURE; ERYTHROCYTE LEVEL; EX VIVO STUDY; FAT INTAKE; FATTY ACID ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN CELL; HYPERTRIGLYCERIDEMIA; INTERVENTION STUDY; LIPID COMPOSITION; MAJOR CLINICAL STUDY; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

17S-HDHA; 17S-HYDROXY-DOCOSAHEXAENOIC ACID; AA; ALA; ARACHIDONIC ACID; BF(3); BLOOD LIPIDS; BORON TRIFLUORIDE; C-REACTIVE PROTEIN; CAD; CHD; CLA; CONJUGATED LINOLEIC ACIDS; CORONARY ARTERY DISEASES; CORONARY HEART DISEASE; COX; CRP; CYCLOOXYGENASE; CYP450; CYTOCHROME P450 MONOOXYGENASES; CYTOKINES; DAIRY PRODUCTS; DGLA; DHA; DIHOMO-Γ-LINOLENIC ACID; DOCOSAHEXAENOIC ACID; EICOSANOIDS; EICOSAPENTAENOIC ACID; EPA; FAME; FATTY ACID METHYL ESTERS; FFP; FOOD FREQUENCY PROTOCOL; HDL; HEPE; HETE; HETRE; HIGH DENSITY LIPOPROTEIN; HODE; HYDROXY-EICOSAPENTAENOIC ACID; HYDROXY-EICOSATETRAENOIC ACID; HYDROXY-EICOSATRIENOIC ACID; HYDROXY-OCTADECAENOIC ACID; IFN; IL; INTERFERON; INTERLEUKIN; LA; LDL; LEUKOTRIENES; LINOLEIC ACID; LIPOPOLYSACCHARIDE; LIPOXYGENASE; LOW DENSITY LIPOPROTEIN; LOX; LPS; LT; MONOUNSATURATED FATTY ACIDS; MUFA; N-3 LC-PUFA; N-3 LONG-CHAIN POLYUNSATURATED FATTY ACIDS; OC; OSTEOCLAST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PG; PL; PLASMA LIPIDS; PPAR; PROSTAGLANDINS; RBC; RED BLOOD CELLS; RELATIVE RATIOS; RESOLVIN; RRS; RV; SATURATED FATTY ACIDS; SFA; SINGLE NUCLEOTIDE POLYMORPHISMS; SNPS; SREBPS; STEROL REGULATORY ELEMENT-BINDING PROTEINS; TAG; TBX; TC; THIN LAYER CHROMATOGRAPHY; THROMBOXANES; TLC; TNFΑ; TOTAL CHOLESTEROL; TRIACYLGLYCERIDES; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN; VLDL; Α-LINOLENIC ACID;

AGED; ANTIGENS, CD36; CARDIOVASCULAR DISEASES; DOUBLE-BLIND METHOD; EICOSANOIDS; ERYTHROCYTES; FATTY ACIDS, OMEGA-3; FEMALE; FOOD, FORTIFIED; GENETIC ASSOCIATION STUDIES; GERMANY; HUMANS; HYPERTRIGLYCERIDEMIA; HYPOLIPIDEMIC AGENTS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; YOGURT;

EID: 84883556561     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2012.12.010     Document Type: Article

References (28)

1. Simopoulos A.P. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic disease. Biomed Pharmacother 2002, 60:502-507.
2. Simopoulos A.P. Omega-3 fatty acids in inflammation and autoimmune diseases. JAm Coll Nutr 2002, 21:495-505.
3. European Food Safety Authorithy (EFSA) Scientific opinion on the substantiation of health claims related to EPA, DHA, DPA and maintenance of normal blood pressure (ID 502), maintenance of normal HDL-cholesterol concentrations (ID 515), maintenance of normal (fasting) blood concentrations of triglycerides (ID 517), maintenance of normal LDL-cholesterol concentrations (ID 528, 698) and maintenance of joints (ID 503, 505, 507, 511, 518, 524, 526, 535, 537) pursuant to article 13(1) of regulation (EC) No 1924/2006. EFSA J 2009, 7:1263.
4. Linseisen J., Kesse E., Slimani N., Bueno-De-Mesquita H.B., Ocké M.C., Skeie G., et al. Meat consumption in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts: results from 24-hour dietary recalls. Public Health Nutr 2002, 5:1243-1258.
5. Calder P.C. Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale. Biochimie 2009, 91:791-795.
6. Zampelas A. Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability. Atherosclerosis 2010, 212:34-35.
7. Milte C.M., Coates A.M., Buckley J.D., Hill A.M., Howe P.R. Dose-dependent effects of docosahexaenoic acid-rich fish oil on erythrocyte docosahexaenoic acid and blood lipid levels. Br J Nutr 2008, 99:1083-1088.
8. Jaudszus A., Krokowski M., Möckel P., Darcan Y., Avagyan A., Matricardi P., et al. Cis-9, trans-11-conjugated linoleic acid inhibits allergic sensitization and airway inflammation via a PPARgamma-related mechanism in mice. JNutr 2008, 138:1336-1342.
9. Madden J., Carrero J.J., Brunner A., Dastur N., Shearman C.P., Calder P.C., et al. Polymorphisms in the CD36 gene modulate the ability of fish oil supplements to lower fasting plasma triacyl glycerol and raise HDL cholesterol concentrations in healthy middle-aged men. Prostaglandins Leukot Essent Fatty Acids 2008, 78:327-335.
10. Blight E.G., Dyer W.J. Arapid method of total lipid extraction and purification. Can J Biochem Physiol 1959, 37:911-917.
11. Kraft J., Collomb M., Möckel P., Sieber R., Jahreis G. Differences in CLA isomer distribution of cow's milk lipids. Lipids 2003, 38:657-664.
12. Masoodi M., Mir A.A., Petasis N.A., Serhan C.N., Nicolaou A. Simultaneous lipidomic analysis of three families of bioactive lipid mediators leukotrienes, resolvins, protectins and related hydroxy-fatty acids by liquid chromatography/electrospray ionisation tandem mass spectrometry. Rapid Commun Mass Spectrom 2008, 22:75-83.
13. Kuhnt K., Kraft J., Vogelsang H., Eder K., Kratzsch J., Jahreis G. Dietary supplementation with trans-11- and trans-12-18: 1 increases cis-9, trans-11-conjugated linoleic acid in human immune cells, but without effectsonbiomarkers of immune function and inflammation. Br J Nutr 2007, 97:1196-1205.
14. Bonfield J.K., Smith K., Staden R. Anew DNA sequence assembly program. Nucleic Acids Res 1995, 23:4992-4999.
15. Natarajan R., Gerrity R.G., Gu J.L., Lanting L., Thomas L., Nadler J.L. Role of 12-lipoxygenase and oxidant stress in hyperglycaemia-induced acceleration of atherosclerosis in a diabetic pig model. Diabetologia 2002 Jan, 45(1):125-133.
16. Yoshida Y., Niki E. Bio-markers of lipid peroxidation invivo: hydroxyoctadecadienoic acid and hydroxycholesterol. Biofactors 2006, 27:195-202.
17. Shishehbor M.H., Zhang R., Medina H., Brennan M.L., Brennan D.M., Ellis S.G., et al. Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease. Free Radic Biol Med 2006, 41:1678-1683.
18. Bagga D., Wang L., Farias-Eisner R., Glaspy J.A., Reddy S.T. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci U S A 2003, 100:1751-1756.
19. Miles E.A., Allen E., Calder P.C. Invitro effects of eicosanoids derived from different 20-carbon Fatty acids on production of monocyte-derived cytokines in human whole blood cultures. Cytokine 2002, 20:215-223.
20. Poulsen R.C., Gotlinger K.H., Serhan C.N., Kruger M.C. Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomicprofiles with ovariectomy and omega-3 intake. Am J Hematol 2008, 83:437-445.
21. Shearer G.C., Harris W.S., Pedersen T.L., Newman J.W. Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters. JLipid Res 2010, 51:2074-2081.
22. Tuttolomondo A., Di Raimondo D., Pecoraro R., Serio A., D'Aguanno G., Pinto A., et al. Immune-inflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke. Atherosclerosis 2010, 213:311-318.
23. Miles E.A., Banerjee T., Wells S.J., Calder P.C. Limited effect of eicosapentaenoic acid on T-lymphocyte and natural killer cell numbers and functions in healthy young males. Nutrition 2006, 22:512-519.
24. Sijben J.W., Calder P.C. Differential immunomodulation with long-chain n-3 PUFA in health and chronic disease. Proc Nutr Soc 2007, 66:237-259.
25. Stark K.D., Holub B.J. Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy. Am J Clin Nutr 2004, 79:765-773.
26. Hokanson J.E., Austin M.A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. JCardiovasc Risk 1996, 3:213-219.
27. Harris W.S., Von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease?. Prev Med 2004, 39:212-220.
28. Hajri T., Abumrad N.A. Fatty acid transport across membranes: relevance to nutrition and metabolic pathology. Annu Rev Nutr 2002, 22:383-415.